What happened
Shares of Innate Pharma(NASDAQ:IPHA), a clinical-stage biotechnology company, are rocketing higher in response to successful clinical-trial data for an experimental cancer drug called monalizumab. Investors surprised by the results pushed…
Here’s Why Innate Pharma Stock Is Rocketing Higher Today
Share this article
More News
Markets Rise as Peace Talks Progress
April 13, 2026
Kenanga Investors wins seven awards at Asia Asset Management
April 13, 2026
